Ironwood pharmaceuticals inc.官网
WebApr 12, 2024 · Ironwood Pharmaceuticals, Inc. has a 1 year low of $9.73 and a 1 year high of $12.66. The company has a market cap of $1.66 billion, a price-to-earnings ratio of 11.10 and a beta of 0.95. WebIronwood Pharmaceuticals is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI … Mr. Emany has served as our chief financial officer since December 2024. Prior to … The Boston Globe named Ironwood Pharmaceuticals a Top Place to Work for … Our in-market product, LINZESS® (linaclotide), discovered in-house, is the … Ironwood Pharmaceuticals wants to make our careers website accessible to all … In November 2024 into a collaboration and license option agreement with COUR … Ironwood Pharmaceuticals. 100 Summer Street Suite 2300 Boston MA 02110. … At Ironwood, how we do things is as important as what we do. Ironwood … By providing your email address below, you are providing consent to Ironwood … One in five Americans suffer from GI diseases, resulting in millions of hospital …
Ironwood pharmaceuticals inc.官网
Did you know?
WebJul 22, 2024 · BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced it will host its second quarter 2024 investor update conference call and webcast at 8:30 a.m. Eastern Time on Thursday, August 5, 2024. Individuals interested in participating in the call should dial (833) 350-1432 (U.S. and Canada) or (647) 689-6932 … WebAbout us. At Ironwood Pharmaceuticals, we are committed to advancing the treatment of GI diseases and redefining the standard of care for GI patients. As a pioneer and champion …
WebApr 10, 2024 · See how Ironwood Pharmaceuticals compares to its main competitors: Hoffmann-LA Roche Inc has the most employees (101,200). Employees at AstraZeneca earn more than most of the competitors, with an average yearly salary of $112,988. Web1 day ago · Ironwood Pharmaceuticals Reports Second Quarter 2024 Results; Maintains Full Year Guidance Due to Continued Strength of LINZESS® Prescription Demand. BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today reported its second quarter 2024 results and recent business performance.
WebAug 3, 2024 · BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD), a GI-focused healthcare company, today announced the appointment of John Minardo as senior vice president, chief legal officer. Mr. Minardo will become a member of Ironwood's Leadership Team and oversee the company's Corporate Legal, Compliance … WebDec 23, 2024 · Ironwood Pharmaceuticals Posts Flat Q4 Adjusted Profit, Revenue Drops; Sets Fiscal 2024.. Transcript : Ironwood Pharmaceuticals, Inc., Q4 2024 Earnings Call, Feb 16, 2.. Analyst Recommendations on IRONWOOD PHARMACEUTICALS, INC. Wells Fargo Adjusts Ironwood Pharmaceuticals' Price Target to $13 from $12, Maintains E..
WebConnect Pharmaceuticals Llc is located at 621 E State St, EAGLE 83616, United States. You can call them via phone number 2082442091. Directionus.com. Connect Pharmaceuticals …
WebApr 15, 2024 · The stock, however, is off -83.80% from where it was a year ago. Additionally, there is a loss of -2.06% for Cumberland Pharmaceuticals Inc. (CPIX) in last trading while the stock has seen an overall depriciation of -26.73%% over the past year. The PE ratio stands at 11.39 for Ironwood Pharmaceuticals Inc., compared to 70.08 for AstraZeneca PLC. fishing in alaska in augustWebIronwood Pharmaceuticals contact info: Phone number: (617) 621-7722 Website: www.ironwoodpharma.com What does Ironwood Pharmaceuticals do? Ironwood … fishing in a lake in the summerWebApr 12, 2024 · A high-level overview of Ironwood Pharmaceuticals, Inc. (IRWD) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. can black seed oil raise blood pressureWebApr 10, 2024 · Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C (GC-C) agonist for the treatment of adults suffering from irritable bowel syndrome with constipation or chronic idiopathic constipation under the LINZESS … fishing in alterac valley classicWebApr 14, 2024 · Ironwood Pharmaceuticals stock opened at $11.10 on Friday. The company has a 50-day simple moving average of $10.97 and a 200-day simple moving average of $11.23. The firm has a market ... can black sesame seeds reverse gray hairWebNov 4, 2024 · Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today reported financial results for third quarter 2024. “We remain hi can blacksmiths drop obsidianWebOct 23, 2012 · Tuesday, 23 October 2012. AstraZeneca and Ironwood Pharmaceuticals, Inc. announced today an agreement to co-develop and co-commercialise Ironwood’s linaclotide in China. Linaclotide is the first and only guanylate cyclase-C (GC-C) agonist approved by the US Food and Drug Administration, in August, for irritable bowel syndrome with ... fishing in alderney